PER
Click for more information
1.19% 8.5¢ percheron therapeutics limited

Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial, page-29

  1. SAtoe3
    91 Posts.
    lightbulb Created with Sketch. 44
    clock Created with Sketch.
    09/06/23
    07:28
    Post #: 68208022
    I was thinking that a review occurs at the 6month mark before they move the placebo kids over to ALT, but I guess not. Txs for the response
    ANP Price at posting: 7.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢ 		Change
0.001(1.19%) 		Mkt cap ! $76.63M
Open High Low Value Volume
8.3¢ 8.5¢ 8.3¢ $32.58K 385.2K

Buyers (Bids)

No. Vol. Price($)
1 3647 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 8842 1
View Market Depth
Last trade - 16.10pm 04/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.